161 related articles for article (PubMed ID: 28724166)
1. Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate).
Leary A; Barthe L; Clavel T; Sanchez C; Issiakhem Z; Paillard B; Edmond JM
Drug Res (Stuttg); 2017 Nov; 67(11):647-652. PubMed ID: 28724166
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Ferrous Sulphate (Tardyferon®) after Single Oral Dose Administration in Women with Iron Deficiency Anaemia.
Leary A; Barthe L; Clavel T; Sanchez C; Oulmi-Castel M; Paillard B; Edmond JM; Brunner V
Drug Res (Stuttg); 2016 Jan; 66(1):51-6. PubMed ID: 25989284
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effectiveness and tolerance of Aktiferrin, a ferrous sulfate capsule preparation and Tardyferon pills in patients with uncomplicated sideropenic anemia].
Mistrík M; Prümmerová J; Oravská D; Gazová S; Chabronová I; Letkovicová M; Sakalová A
Cas Lek Cesk; 1995 Oct; 134(20):666-8. PubMed ID: 7489584
[TBL] [Abstract][Full Text] [Related]
4. [Statement of the Polish Gynecological Society Expert Group on the use of iron preparations (Tardyferon, Tardyferon-Fol) in obstetrics and gynaecology].
Polish Gynecological Society Expert Group
Ginekol Pol; 2013 Jan; 84(1):72-4. PubMed ID: 23488315
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial.
Zaim M; Piselli L; Fioravanti P; Kanony-Truc C
Eur J Nutr; 2012 Mar; 51(2):221-9. PubMed ID: 21643774
[TBL] [Abstract][Full Text] [Related]
6. [Anemia and its treatment with peroral anti-anemia agents in women during the postpartum period].
Mára M; Eretová V; Zivný J; Kvasnicka J; Umlaufová A; Márová E
Ceska Gynekol; 1999 Jun; 64(3):153-8. PubMed ID: 10568044
[TBL] [Abstract][Full Text] [Related]
7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
Casparis D; Del Carlo P; Branconi F; Grossi A; Merante D; Gafforio L
Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381
[TBL] [Abstract][Full Text] [Related]
9. [Tardyferon-depot in the treatment of iron deficiency anemia].
Hołowiecki J; Stella-Hołowiecka B; Harbut-Gryłka A
Acta Haematol Pol; 1976 OCT-DEC; 7(4):321-5. PubMed ID: 998142
[TBL] [Abstract][Full Text] [Related]
10. [Comparative clinical evaluation of 2 prolonged-action iron preparations--Tardyferon and Ferrogradumet].
Wysocki H; Nowicka G; Wierusz B; Wysocki K
Pol Tyg Lek; 1977 Jun; 32(26):1017-9. PubMed ID: 882449
[No Abstract] [Full Text] [Related]
11. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia.
Adsul BB; Desai A; Gawde A; Baliga V
J Indian Med Assoc; 2005 Jun; 103(6):338-42. PubMed ID: 16225161
[TBL] [Abstract][Full Text] [Related]
12. [Iron deficiency anemia in pregnant women and its management with gino-tardyferon].
Sokolova MIu; Nikonov AP
Ter Arkh; 2003; 75(7):87-8. PubMed ID: 12934491
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: an interventional study.
Paesano R; Pacifici E; Benedetti S; Berlutti F; Frioni A; Polimeni A; Valenti P
Biometals; 2014 Oct; 27(5):999-1006. PubMed ID: 24590680
[TBL] [Abstract][Full Text] [Related]
14. [Tardyferon in obstetric and gynecological practice].
Stoianova V
Akush Ginekol (Sofiia); 2006; 45 Suppl 3():76-7. PubMed ID: 18240733
[No Abstract] [Full Text] [Related]
15. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview.
Santiago P
ScientificWorldJournal; 2012; 2012():846824. PubMed ID: 22654638
[TBL] [Abstract][Full Text] [Related]
16. Treatment of iron-deficiency anaemia of infancy with bebe-tardyferon depot coated tablet.
Révész T; Kardos G
Ther Hung; 1985; 33(4):207-10. PubMed ID: 3842019
[No Abstract] [Full Text] [Related]
17. Tardyferon therapy in hyposiderosis of infancy and childhood.
Horváth K; Horn G
Ther Hung; 1992; 40(1):40-3. PubMed ID: 1585284
[TBL] [Abstract][Full Text] [Related]
18. Ferrous sulfate oral solution in young children with iron deficiency anemia: An open-label trial of efficacy, safety, and acceptability.
Pachuta Węgier L; Kubiak M; Liebert A; Clavel T; Montagne A; Stennevin A; Roye S; Boudribila A
Pediatr Int; 2020 Jul; 62(7):820-827. PubMed ID: 32191814
[TBL] [Abstract][Full Text] [Related]
19. [The use of tardyferon in the combined treatment of patients with chronic atrophic gastritis and peptic ulcer complicated by hemorrhage].
Kharchenko NV; Degtiareva II; Rodonezhskaia EV; Levin IV
Lik Sprava; 1995; (5-6):87-91. PubMed ID: 8630823
[TBL] [Abstract][Full Text] [Related]
20. Correction: Iron Pharmacokinetics in Women with Iron Deficiency Anaemia Following A Single Oral Dose of a Novel Formulation of Tardyferon (Prolonged Release Ferrous Sulphate).
Leary A; Barthe L; Clavel T; Sanchez C; Issiakhem Z; Paillard B; Edmond JM
Drug Res (Stuttg); 2017 Nov; 67(11):e1. PubMed ID: 29207435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
